Lv01
0 积分 2023-07-28 加入
Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment
6小时前
待确认
Shikonin and chitosan-silver nanoparticles synergize against triple-negative breast cancer through RIPK3-triggered necroptotic immunogenic cell death
6小时前
已完结
Copy number alteration signatures as biomarkers in cancer: a review
1年前
已完结
The repertoire of copy number alteration signatures in human cancer
1年前
已完结
Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy
1年前
已完结
Copy number alteration signatures as biomarkers in cancer: a review
1年前
已完结
Cancer aneuploidies are shaped primarily by effects on tumour fitness
1年前
已完结
皖公网安备34019202002308
